Why it was recalled
Defective container: Product distributed without inner seal on bottles.
Product description
Metformin Hydrochloride Tablets USP 1000 mg, 500 tablets Rx Only, Manufactured by Blu Caribe Dorado PR 00646. Distributed by Blu Pharmaceuticals Franklin NY 42134, NDC 24658-0292-05
Lot numbers, UPCs & expiration codes
Lot # 13E0014F1P8V; Exp. 04/15
Where it was sold
NJ, UT, IL and CT
What to do if you have this product
- Compare the lot number and expiration date on your package with the codes above.
- Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
- If you have symptoms you think are related, contact your doctor. In an emergency call 911.
- Report side effects to FDA MedWatch at 1-800-FDA-1088.
Recall details
- Recall number
- D-1302-2014
- Classification
- Class II
- Status
- Terminated
- Recall initiated
- Mar 13, 2014
- FDA report date
- May 14, 2014
- Quantity
- 101,500 tablets
- Recall type
- Voluntary: Firm initiated
- Recalling firm
- Blu Pharmaceuticals Inc
Original FDA data
Every field from FDA enforcement report D-1302-2014, exactly as published.
Show all FDA fields
- City
- Franklin
- State
- KY
- Status
- Terminated
- Country
- United States
- Event ID
- 67739
- Address
- 301 Robey St
- Code information
- Lot # 13E0014F1P8V; Exp. 04/15
- Postal code
- 42134-1032
- Report date
- May 14, 2014
- Product type
- Drugs
- Recall number
- D-1302-2014
- Classification
- Class II
- Recalling firm
- Blu Pharmaceuticals Inc
- Product quantity
- 101,500 tablets
- Termination date
- Jun 10, 2015
- Reason for recall
- Defective container: Product distributed without inner seal on bottles.
- Voluntary / mandated
- Voluntary: Firm initiated
- Product description
- Metformin Hydrochloride Tablets USP 1000 mg, 500 tablets Rx Only, Manufactured by Blu Caribe Dorado PR 00646. Distributed by Blu Pharmaceuticals Franklin NY 42134, NDC 24658-0292-05
- Distribution pattern
- NJ, UT, IL and CT
- Recall initiation date
- Mar 13, 2014
- Initial firm notification
- Letter
- Center classification date
- May 5, 2014